Effects of Nasal Septal Surgery on Sleep Quality, Daytime and Dream Anxiety
Evaluation of Benefits of Nasal Septal Surgery on Subjective Sleep Quality, Daytime and Dream Anxiety
1 other identifier
observational
68
1 country
1
Brief Summary
The aim of this report was to assess the frequency of poor sleep quality, daytime and dream anxiety and their response to subsequent surgical treatment for a representative group patients with nasal septum deviation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 30, 2012
CompletedFirst Posted
Study publicly available on registry
May 7, 2012
CompletedMay 7, 2012
May 1, 2012
April 30, 2012
May 3, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The amelioration of subjective sleep quality with nasal septal surgery.
The Pittsburgh Sleep Quality Index (PSQI) was used for the evaluations.
A postoperative assessment for the aforementioned parameter was made at two months from the day of the surgery.
The amelioration of daytime anxiety with nasal septal surgery.
The Beck Anxiety Inventory (BAI) was used for the evaluations.
A postoperative assessment for the aforementioned parameter was made at two months from the day of the surgery.
The amelioration of dream anxiety with nasal septal surgery.
The Van Dream Anxiety Scale (VDAS) was used for the evaluations.
A postoperative assessment for the aforementioned parameter was made at two months from the day of the surgery.
Study Arms (1)
The participants with septal deviation
Interventions
In this method, the airflow through 1 nasal cavity and the pressure gradient across this nasal cavity are measured simultaneously at each breath as recommended by the committee report on the standardization of rhinomanometry. All measurements were performed under the same standard conditions. Herein, all presented airflow values are the sum of inspiratory airflow of the right and left sides of the nose at 150 pascals (Pa). And, total nasal airflow (cm3/s) and airway resistance (Pa/cm3/s) values were used for statistical analyses.
PSQI was developed to measure sleep quality during the previous month and to discriminate between good and poor sleepers. The self-administered scale contains 15 multiple-choice items that inquire about frequency of sleep disturbances and subjective sleep quality and 4 write-in items that inquire about typical bedtime, wake-up time, sleep latency, and sleep duration. Each component score ranges from 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range of 0-21). A PSQI global score \>5 is considered to be suggestive of significant sleep disturbance.
The BAI is a 21-item self-report questionnaire that lists symptoms of anxiety. The respondent is asked to rate how much each symptom has bothered him/her in the past week. The symptoms are rated on a four-point scale, ranging from ''not at all'' (0) to ''severely'' (3). The instrument has excellent internal consistency and high test-retest reliability. The BAI has been widely used to measure severity of anxiety by self-report.
The VDAS provides the assessment of nightmare frequency and dream anxiety caused by frightening dreams during the preceding month. There are 17 self-rated questions in the scale. Twelve questions (1-4, 6, 11-17) that are tabulated in the scoring are weighted equally on a 0-4 scale. Question 5 is related to autonomic hyperactivity and consists of 12 symptoms. Each of 12 symptoms is also weighted on a 0-4 scale. Thirteen question scores are summed to yield a global VDAS score, which has a range of 0-42.
Eligibility Criteria
Otorhinolaryngology outpatient clinic
You may qualify if:
- All participants, 18 to 65 years of age, had septal deviation consistent with the presenting symptoms which last at least three months and persist after a three months trial of medical management, including topical nasal steroids, topical or oral decongestants, or an oral antihistamine/decongestant combination.
You may not qualify if:
- Patients were excluded from the study if they had nasal septal surgery performed for other reasons, such as
- an access to nasal and sinus tumors,
- pituitary surgery and as part of treatment for sleep apnea or with concurrent sinus surgery;
- had rhinoplasty prior to submucous resection;
- had acute nasal trauma;
- had adenoid hypertrophy;
- had uncontrolled asthma/nasal allergy;
- had diagnosed or suspected (snoring with/without other symptoms, such as apneas referred by someone and/or somnolence) OSA;
- had obesity (BMI ≥ 30.0 kg/m2);
- had an unstable physical disorder;
- had a current or lifetime history of any functional or organic mental disorder;
- had a history of seizures;
- had a neurological disorder that significantly affects central nervous system functions;
- had met criteria for substance abuse or dependence in the previous 12 months, including nicotine dependence;
- were taking medications that may cause or exacerbate sleep problems, daytime and dream anxiety; had clinical or laboratory evidence of hypothyroidism without adequate and stable replacement therapy;
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ataturk University, Yakutiye Research Hospital
Erzurum, Yakutiye, 25240, Turkey (Türkiye)
Related Publications (2)
Baumann I. Quality of life before and after septoplasty and rhinoplasty. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2010;9:Doc06. doi: 10.3205/cto000070. Epub 2011 Apr 27.
PMID: 22073110BACKGROUNDMoore M, Eccles R. Objective evidence for the efficacy of surgical management of the deviated septum as a treatment for chronic nasal obstruction: a systematic review. Clin Otolaryngol. 2011 Apr;36(2):106-13. doi: 10.1111/j.1749-4486.2011.02279.x.
PMID: 21332671BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mustafa Gulec, investigator
Ataturk University, Faculty of Medicine, Department of Psychiatry
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., Psych., Assist. Prof.
Study Record Dates
First Submitted
April 30, 2012
First Posted
May 7, 2012
Study Start
October 1, 2010
Study Completion
April 1, 2012
Last Updated
May 7, 2012
Record last verified: 2012-05